The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge.
about
Th17-mediated inflammation in asthmaProtocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approachUsing magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitisA Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13)IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infectionIL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner.Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune ResponsivenessIL-17A induces signal transducers and activators of transcription-6-independent airway mucous cell metaplasia.Targeting eosinophils in allergy, inflammation and beyond.Cytokine profiles in allergic rhinitis.The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement.Neonatal cytokine profile in the airway mucosal lining fluid is skewed by maternal atopy.Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals.Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited.Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples.Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement.
P2860
Q26861492-A8DF4151-7E6E-41E9-BC9E-A8148DD60BEEQ28650506-1DB03933-03F1-408A-A158-62D5977135ADQ30394467-D950D251-4BB2-4015-9BB9-4D759BFCB302Q33715731-7532E9C3-89A6-4595-B0C6-C403D9512A38Q34825559-A19CC0C1-6EDF-4DB7-9473-755DD4AC4A9AQ34987195-55FEB1F1-DBFE-4F4E-BD83-615CB8470B90Q35685575-38C8941C-9B56-424F-B27E-D53E1171ACD1Q35772526-059B07E9-6F33-40E9-A067-C0AE08963012Q37056449-979E30BF-EDCE-497B-A2B8-9C801BDCFE9CQ38075409-E432EDC7-996C-43E1-A3DF-065C988DD1E8Q38196334-90B96A29-5316-4AFF-ABC2-0F72807AB826Q38817069-F37997C0-AF36-4775-990C-4355E5011792Q40306192-CE363299-AE69-4573-A0F0-12C30EF9DFABQ43736543-B7F21FEC-95FC-4B63-8F18-508104E12F04Q45874675-2A486F5B-188C-48BA-9C1F-1C1D4B14A4FDQ47339266-9E2DE9BB-FA0D-41C5-B39B-D7BF005C7AB2Q50009517-0B4CE5E1-DD44-4D20-9E75-F5D5B1047E89Q55277398-C687A013-E52F-4A20-B19B-5C239B19BEC1
P2860
The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The effects of an anti-IL-13 m ...... wing nasal allergen challenge.
@en
type
label
The effects of an anti-IL-13 m ...... wing nasal allergen challenge.
@en
prefLabel
The effects of an anti-IL-13 m ...... wing nasal allergen challenge.
@en
P2093
P1476
The effects of an anti-IL-13 m ...... wing nasal allergen challenge.
@en
P2093
Andrew J Tan
Christoph Walker
David Rodman
Deborah Quinn
Grant C Nicholson
Harsha H Kariyawasam
John Westwick
Norbert Krug
Peter J Barnes
Stipo Jurcevic
P304
800-807.e9
P356
10.1016/J.JACI.2011.05.013
P407
P577
2011-06-29T00:00:00Z